Kyowa Kirin

Clinical Trial SponsorPrivate Company

Tokyo, Japan

Website

1949

Founded

500-5,000

Employees

About Kyowa Kirin

Kyowa Kirin is a Japan-based Global Specialty Pharmaceutical Company, contributing to human health and well-being worldwide through innovative drug discovery and global commercialization, driven by state-of-the-art antibody technologies, in the core therapeutic areas of oncology, nephrology, central nervous system and immunology. Kyowa Kirin delivers life-changing value in rare diseases, and is among the 40 largest in the world by revenue. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index.

Therapeutic areas

Rare Diseases Genetic Disorders Oncology Immunology Pediatrics

Experience & capabilities

Products:Medical DevicesTherapeutic products

Trial geography:GlobalEuropeJapanHong KongChinaSouth Korea (Republic of Korea)United States of AmericaAustralia

Browse companies by location

Tokyo, Japan Japan

At IGI, we strive to fast-track the development of new cancer cures through collaboration. We focus on creating cutting-edge solutions to treat hematological malignancies and…